Prati
Petra Grbčić
Petra Grbčić
Juraj Dobrila University of Pula
Potvrđena adresa e-pošte na unipu.hr
Naslov
Citirano
Citirano
Godina
Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer
A Bistrović, L Krstulović, A Harej, P Grbčić, M Sedić, S Koštrun, SK Pavelić, ...
European journal of medicinal chemistry 143, 1616-1634, 2018
1012018
Novel pyrimidine-2, 4-dione–1, 2, 3-triazole and furo [2, 3-d] pyrimidine-2-one–1, 2, 3-triazole hybrids as potential anti-cancer agents: synthesis, computational and X-ray …
T Gregorić, M Sedić, P Grbčić, AT Paravić, SK Pavelić, M Cetina, ...
European journal of medicinal chemistry 125, 1247-1267, 2017
872017
Preparation of Multifunctional N-Doped Carbon Quantum Dots from Citrus clementina Peel: Investigating Targeted Pharmacological Activities and the Potential Application for …
S Šafranko, A Stanković, S Hajra, HJ Kim, I Strelec, M Dutour-Sikirić, ...
Pharmaceuticals 14 (9), 857, 2021
342021
Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
P Grbčić, I Tomljanović, M Klobučar, SK Pavelić, K Lučin, M Sedić
Biochemical and biophysical research communications 487 (4), 782-788, 2017
312017
Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549
A Bistrović, P Grbčić, A Harej, M Sedić, S Kraljević-Pavelić, S Koštrun, ...
Journal of enzyme inhibition and medicinal chemistry 33 (1), 271-285, 2018
262018
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK− mediated signalling
M Klobučar, P Grbčić, SK Pavelić, N Jonjić, S Visentin, M Sedić
Biochemical and biophysical research communications 503 (2), 843-848, 2018
252018
Bioactive sphingolipids as biomarkers predictive of disease severity and treatment response in cancer: current status and translational challenges
M Sedić, P Grbčić, SK Pavelić
Anticancer research 39 (1), 41-56, 2019
202019
Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl …
L Racané, L Ptiček, M Sedić, P Grbčić, S Kraljević Pavelić, B Bertoša, ...
Molecular diversity 22, 723-741, 2018
182018
Sphingosine 1-phosphate signaling and metabolism in chemoprevention and chemoresistance in colon cancer
P Grbčić, M Sedić
Molecules 25 (10), 2436, 2020
172020
Amidino substituted 2-aminophenols: Biologically important building blocks for the amidino-functionalization of 2-substituted benzoxazoles
L Ptiček, L Hok, P Grbčić, F Topić, M Cetina, K Rissanen, SK Pavelić, ...
Organic & biomolecular chemistry 19 (12), 2784-2793, 2021
122021
Metabolite characterization, antioxidant, anti-proliferative and enzyme inhibitory activities of Lophira lanceolata Tiegh. ex Keay extracts
KI Sinan, LS Martinović, Ž Peršurić, SK Pavelić, P Grbčić, D Matulja, ...
Industrial crops and products 158, 112982, 2020
122020
Purine and purine isostere derivatives of ferrocene: An evaluation of ADME, antitumor and electrochemical properties
V Rep, M Piškor, H Šimek, P Mišetić, P Grbčić, J Padovan, ...
Molecules 25 (7), 1570, 2020
122020
Synthesis, antiproliferative and antitrypanosomal activities, and DNA binding of novel 6-amidino-2-arylbenzothiazoles
L Racané, V Rep, S Kraljević Pavelić, P Grbčić, I Zonjić, M Radić Stojković, ...
Journal of enzyme inhibition and medicinal chemistry 36 (1), 1952-1967, 2021
112021
Targeting ceramide metabolism in hepatocellular carcinoma: new points for therapeutic intervention
P Grbčić, EPM Car, M Sedić
Current medicinal chemistry 27 (39), 6611-6627, 2020
112020
In Vitro Photodynamic Activity of N‐Methylated and N‐Oxidised Tripyridyl Porphyrins with Long Alkyl Chains and Their Inhibitory Activity in Sphingolipid Metabolism
M Jelovica, P Grbčić, M Mušković, M Sedić, SK Pavelić, M Lončarić, ...
ChemMedChem 13 (4), 360-372, 2018
112018
Synthesis and anti-proliferative effects of mono-and bis-purinomimetics targeting kinases
A Bistrović, A Harej, P Grbčić, M Sedić, S Kraljević Pavelić, M Cetina, ...
International journal of molecular sciences 18 (11), 2292, 2017
112017
The sphingosine kinase 2 inhibitor ABC294640 restores the sensitivity of BRAFV600E mutant colon cancer cells to vemurafenib by reducing AKT-mediated expression of nucleophosmin …
P Grbčić, TO Eichmann, S Kraljević Pavelić, M Sedić
International Journal of Molecular Sciences 22 (19), 10767, 2021
92021
Proteomic profiling of BRAFV600E mutant colon cancer cells reveals the involvement of nucleophosmin/c-Myc axis in modulating the response and resistance to BRAF inhibition by …
P Grbčić, D Fučkar Čupić, T Gamberi, S Kraljević Pavelić, M Sedić
International journal of molecular sciences 22 (12), 6174, 2021
92021
Treatment with medicinal mushroom extract mixture inhibits translation and reprograms metabolism in advanced colorectal cancer animal model as evidenced by tandem mass tags …
B Jakopovic, A Horvatić, M Klobučar, A Gelemanović, P Grbčić, N Oršolić, ...
Frontiers in pharmacology 11, 1202, 2020
82020
Chemical evaluation, antioxidant, antiproliferative, anti-inflammatory and antibacterial activities of organic extract and semi-purified fractions of the Adriatic sea fan …
D Matulja, P Grbčić, K Bojanić, N Topić-Popović, R Čož-Rakovac, S Laclef, ...
Molecules 26 (19), 5751, 2021
62021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20